Clinical Trial Update: Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 clinical trial evaluating intravitreal bevacizumab for active progressive proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Retinopathy | Phase 3 | Status: UNKNOWN